by Corinne Gangloff
September 27, 2019
As major drug makers from Johnson & Johnson to Purdue Pharma face mounting legal challenges for their role in the US opioid epidemic, suppliers of the $94 billion global pharmaceutical packaging industry are using innovation to comply with regulations aimed at preventing such crises in the future.
Among these developments, stricter anticounterfeiting and anti-diversion measures in mature markets – such as the Drug Supply Chain Security Act in the US – are driving demand for higher-value packaging solutions that can help reduce prescription nonadherence among patients and facilitate product tracing from point of manufacture to sale, among other capabilities. Accordingly, the products with the fastest anticipated demand growth through 2023 are:
Rising packaging standards in mature markets affect developing markets, too
Developing countries including China and India are improving pharmaceutical packaging systems as multinationals move in to capitalize on pharmaceutical market expansion in these former export markets:
Looking for More?
Global Pharmaceutical Packaging, a new study from The Freedonia Group, analyzes the global pharmaceutical packaging market, presenting historical demand data (2008, 2013, and 2018) and forecasts for 2023 by product group (primary pharmaceutical containers, pharmaceutical closures, secondary pharmaceutical containers, pharmaceutical labels, pharmaceutical packaging accessories), and regions (North America, Central and South America, Western Europe, Eastern Europe, Asia/Pacific, and Africa/Mideast). The study also provides company market share and analysis on industry participants like Amcor, West Pharmaceutical Services, Becton Dickinson, Gerresheimer, CCL Industries, and more.
Provide the following details to subscribe.